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OBJECTIVE—Exercise is an important strategy for the treat-
ment of type 2 diabetes. This is due in part to an increase in
glucose transport that occurs in the working skeletal muscles.
Glucose transport is regulated by GLUT4 translocation in mus-
cle, but the molecular machinery mediating this process is poorly
understood. The purpose of this study was to 1) use a novel
imaging system to elucidate the kinetics of contraction-induced
GLUT4 translocation in skeletal muscle and 2) determine the
function of AMP-activated protein kinase 2 (AMPK2) in this
process.
RESEARCH DESIGN AND METHODS—Confocal imaging
was used to visualize GLUT4-enhanced green ﬂuorescent protein
(EGFP) in transfected quadriceps muscle ﬁbers in living mice
subjected to contractions or the AMPK-activator AICAR.
RESULTS—Contraction increased GLUT4-EGFP translocation
from intracellular vesicle depots to both the sarcolemma and
t-tubules with similar kinetics, although translocation was
greater with contractions elicited by higher voltage. Re-internal-
ization of GLUT4 did not begin until 10 min after contractions
ceased and was not complete until 130 min after contractions.
AICAR increased GLUT4-EGFP translocation to both sarco-
lemma and t-tubules with similar kinetics. Ablation of AMPK2
activity in AMPK2 inactive transgenic mice did not change
GLUT4-EGFPs basal localization, contraction-stimulated intra-
cellular GLUT4-EGFP vesicle depletion, translocation, or re-
internalization, but diminished AICAR-induced translocation.
CONCLUSIONS—We have developed a novel imaging system
to study contraction-stimulated GLUT4 translocation in living
mice. Contractions increase GLUT4 translocation to the sarco-
lemma and t-tubules with similar kinetics and do not require
AMPK2 activity. Diabetes 59:2134–2144, 2010
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keletal muscle is critical in the regulation of
glucose homeostasis, being the major site of
whole-body glucose disposal (1). In skeletal mus-
cle ﬁbers, the GLUT4 protein mediates increases
in glucose uptake. Upon stimulation with insulin or muscle
contraction, GLUT4 is translocated from intracellular ves-
icle compartments to the two main muscle membrane
surfaces, the sarcolemma and t-tubules (2–5). The kinetics
of GLUT4 intracellular trafﬁcking in skeletal muscle and
how signaling molecules regulate GLUT4 translocation are
poorly understood, especially for contraction-mediated
GLUT4 translocation. The majority of studies analyzing
GLUT4 translocation dynamics have been carried out in
adipocytes (6–10) or in muscle cell cultures (11–13), cell
types that do not resemble fully differentiated muscle (14).
Recently, intravital imaging techniques have allowed
detailed analysis of the spatial-temporal dynamics of
GLUT4 translocation in response to insulin stimulation in
skeletal muscle ﬁbers of living animals (5,15,16). Direct
imaging of insulin-stimulated GLUT4-EGFP translocation
has shown that GLUT4 is translocated to both the sarco-
lemma and t-tubules. Both GLUT4 translocation and re-
internalization were delayed in the t-tubules compared
with the sarcolemma due to a lag in insulin diffusion (5,16).
These imaging studies have also shown that in states of
insulin resistance, the t-tubules, and not the sarcolemma,
are the primary site of impaired insulin signaling and
GLUT4 translocation (16). Collectively, these ﬁndings il-
lustrate that insulin-mediated signaling and GLUT4 trans-
location are compartmentalized in mature skeletal muscle
ﬁbers.
It is unknown whether a similar type of compartmental-
ization exists for contraction-mediated GLUT4 transloca-
tion. It is well established that rapid spreading of
membrane depolarization throughout the t-tubule network
results in simultaneous activation of contraction through-
out the muscle ﬁber (17).
Biochemical studies have suggested that in response to
muscle contraction, GLUT4 can translocate to both the
sarcolemma and t-tubules (4,18). However, imaging stud-
ies have never been done in intact contracting skeletal
muscle to analyze the kinetics of GLUT4 translocation in
high resolution.
The signaling mechanisms mediating contraction-in-
duced GLUT4 translocation are not fully understood, but
differ from those triggered by insulin (19). Muscle contrac-
tions increase AMPK activity (20), and pharmacological
activation of AMPK results in increased glucose transport
in skeletal muscle (20–22), although one report suggested
that AICAR only caused GLUT4 translocation to the sar-
colemma (23). Surprisingly, studies directly assessing the
role of AMPK in contraction-mediated glucose transport
using animal models with ablated AMPK activity have
been ambiguous. Contraction-mediated glucose transport
was not impaired in whole-body knockouts of the
AMPK1 or AMPK2 catalytic subunits (24). In muscle-
speciﬁc AMPK2 inactive transgenic mice, contraction- or
exercise-mediated glucose transport was either partially
reduced (25,26) or unaffected (27,28), but the effects of
AMPK activity on GLUT4 translocation kinetics are not
known.
In the current study, we used intravital imaging to
determine GLUT4 translocation kinetics in contracting
skeletal muscle. To understand the intracellular signals
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inactive transgenic mice (27). We found that contraction-
stimulated GLUT4 translocation occurs at both the sarco-
lemma and t-tubules with similar kinetics. Our data
demonstrate that contractions elicited by a higher voltage
resulted in a higher degree of translocation, and that
GLUT4 remains at the cell surface for up to 2 h after the
cessation of contraction. Finally, our data show that
contraction-stimulated GLUT4 translocation is AMPK2-
independent.
RESEARCH DESIGN AND METHODS
Protocols complied with the guidelines of the Institutional Animal Care and
Use Committee of the Joslin Diabetes Center and the National Institutes of
Health. Male Imprinting Control Region (ICR) mice (aged 7–10 weeks)
(Taconic, Hudson, NY), AMPK2 inactive transgenic mice on an FVB back-
ground, and matched controls were studied (27).
Plasmid and transfection procedures. The construction of GLUT4-EGFP
has been described previously (16,29). Mice were transfected as previously
described (14,29,30). Mice were brieﬂy anesthetized with 90 mg/kg pentobar-
bital i.p., and the skin was opened to expose the quadriceps muscle to the
bombardment of DNA/gold particles using the Helios gene gun system. Each
muscle was shot twice with 200 psi pressure with 1 g DNA/0.5 mg gold (0.6
m gold particle size). After transfection, the skin was closed using sutures
and the animals were allowed to recover.
Time-lapse microscopy. Five days after transfection, mice were anesthe-
tized and mounted in dental cement (5,29). For contraction experiments,
immediately prior to mounting the mice, microelectrodes were placed into the
superﬁcial muscle ﬁber layer near the groin and knee region of the quadriceps
muscle, producing single twitch contractions only in the superﬁcial layers of
the quadriceps muscle ﬁbers without losing imaging focus. Such stimulation
activates muscle ﬁbers via stimulation of the motor nerve ﬁbers and motor
endplates. Stimulation was not applied directly to the nerve because it
resulted in either no visually detectable contractions or entire muscle belly
contractions resulting in loss of optical focus during contraction.
For AICAR stimulation, the mouse was mounted, a catheter was placed in
a tail vein, and a single confocal image was taken. This was followed by an
additional 30-min stabilization period followed by another basal image (t  0).
There was no signiﬁcant difference between the two basal images.
For the contraction protocol, immediately after the second basal image
(t  0), direct electrical stimulation to the muscle ﬁbers was initiated. Two
contraction treatments of different intensities were used: 1) contractions
elicited by lower voltage and the parameters were frequency 2 Hz, duration 60
milliseconds, voltage 0.1–0.9 V, consisting of three bouts of 10 min, separated
by 90 s of rest and 2) contractions elicited by higher voltage and the
parameters were frequency 2 Hz, duration 60 milliseconds, voltage 1.1–3.0 V,
consisting of three bouts of 5 min, separated by 90 s of rest. Both protocols
elicited repeated single twitch contractions. Protocols were selected based on
empirical observations of contraction force taken together with what was
possible without losing optical focus of the imaged muscle ﬁber. We did not
use an increasing contraction frequency because it made it very difﬁcult to
continually monitor ﬁber contraction. In our experience, the voltage ﬁeld
intensity generated by a higher voltage induced visually greater ﬁber contrac-
tion amplitude. This difference in contraction intensity is what we refer to as
high- or low-voltage contractions throughout the study.
Contractions of the imaged ﬁbers were continually monitored during the
contraction periods through the oculars of the microscope, and voltage was
adjusted to maintain force. Images were collected at the end of each
contraction period and every 10-min post-contraction up to 130 min. The
imaging of a high-voltage in situ contraction period is shown in supplementary
video 1 (available online at http://diabetes.diabetesjournals.org/cgi/content/
full/dc10-0233/DC1), illustrating that clear images are not obtainable when the
ﬁbers are contracting.
For AICAR stimulation, AICAR was given as an intravenous bolus injection
(1 g/kg) through the tail vein, and images were collected every 10 min for 240
min. Images were collected with a 63, 1.2 NA Zeiss C-Apochromat objective
on a Zeiss-LSM-410 confocal microscope with ArKr-488 nanometer (nm) laser
line for excitation of EGFP, while green emission light was collected between
500 and 530 nm using the standard ﬂuorescein isothiocyanate ﬁlter. Sulforho-
damine B images were collected as described (5).
Image analysis. The tagged image ﬁle format (TIFF) images obtained with
the Zeiss confocal software were imported into Metamorf Software (version
6.1; Universal Imaging). Image stacks were created, and brightness and
contrast were adjusted. Since it has previously been reported that GLUT4
translocation and re-internalization in muscle are products of endocytosis and
exocytosis movements, we measured the net amount of GLUT4-EGFP at the
various time points (31). The net amount of GLUT4-EGFP at membrane
surfaces was quantiﬁed using Metamorf Software by drawing thin regions of
interest (ROIs) at the sarcolemma and t-tubule regions, excluding vesicle
structures, as previously described (5,15,16). Brieﬂy, intracellular vesicle
depots were quantiﬁed by measuring changes in gray value intensity in
GLUT4-EGFP vesicles larger than 2 m in the visible ﬁber area inside an ROI
covering both sarcolemma and t-tubules (Fig. 1A). The threshold and classi-
fying settings in the Metamorf Software were used to discriminate depots
above 2 m in size from the background and emerging staining of sarcolemma
and t-tubules. These Metamorf settings were also used to further discriminate
between perinuclear and nonperinuclear GLUT4-EGFP depots. For sarco-
lemma, measurements from both sarcolemma edges of the confocal picture
were averaged, the perinuclear areas were excluded, and measurements were
normalized to the area of the sarcolemma ROI (Fig. 1B). For t-tubules,
measurements from four randomly chosen areas were averaged (Fig. 1B). To
compensate for variation in GLUT4-EGFP expression among ﬁbers, the
arbitrary units shown are the actual gray value of ROI ﬂuorescence divided by
ROI ﬂuorescence value at t  0 (f/f0).
To verify the striated appearance and orientation of the t-tubules, we used
sulforhodamine B, a water soluble dye that is not taken up by muscle ﬁbers
but will ﬁll and stain the lumen of the t-tubules (32–34) (Fig. 1C). Sulforho-
damine B was injected into the tail vein, and a confocal picture of quadriceps
ﬁbers was obtained 3 min later when the dye had fully loaded the t-tubules.
Staining resulted in two very strong vertical ﬂorescent lines representing the
capillaries and interstitial space near the sarcolemma and ﬁne striated lines
indicating the lumen of the t-tubules. The difference in the intensity of the
sulforhodamine B staining is due to the much smaller diameter of the t-tubule
lumen (100 nm) compared with the ﬂanking capillaries (40 m) and
interstitial space. This striated pattern for t-tubules is consistent with previous
ﬁndings (4,5,15,35).
Statistical analysis. Gray value means from ROIs were imported into Sigma
plot 10.0. Values obtained at the end of the various contraction bouts (Fig. 1)
and calculated areas under the curve (Fig. 5) were compared between groups
by t test. Data are means  SE, *P  0.05.
RESULTS
Contraction stimulates GLUT4-EGFP translocation
to both the sarcolemma and t-tubules. In the basal
state, GLUT4-EGFP was found in larger and smaller vesi-
cle structures (Fig. 1D and E)( t  0, diagonal arrow) and
in the perinuclear region (t  0, vertical arrow), as has
been previously reported (4,5,16,29,36). There was no
continuous presence at the sarcolemma (Fig. 1D and E)
(t  0, horizontal arrow) and no regular striated pattern
throughout the ﬁber. Following basal imaging, the super-
ﬁcial ﬁbers of the quadriceps were contracted with high or
low voltage. In mice subjected to high voltage contrac-
tions, there was marked staining along the sarcolemma by
the 5 min time point (Fig. 1D)( t  5), quantiﬁed as a 60%
increase above basal (Fig. 1F). A striated pattern emerged
inside the muscle ﬁbers by 5 min showing translocation to
the t-tubules (Fig. 1D)( t  5). Compared with the basal
state, there was a 90% increase in t-tubule GLUT4-EGFP
after 5 min of contraction (Fig. 1G). In parallel, there was
a marked depletion of GLUT4-EGFP vesicles in intracellu-
lar GLUT4-EGFP vesicle depots, which also included the
perinuclear region (Fig. 1D [t  5] and H). Two additional
5-min contraction periods further increased GLUT4-EGFP
staining of sarcolemma and t-tubules (	200% increase
from basal) simultaneously with a further reduction in
GLUT4-EGFP vesicle depots (70% decrease from basal)
(Fig. 1D [t  10, t  15] and H). The depot depletion
corresponded to a 75% maximal reduction in nonpe-
rinuclear depots and a 65% maximal reduction in perinu-
clear depots.
With contractions elicited by low voltage, there was a
signiﬁcant but modest GLUT4-EGFP translocation to the
sarcolemma by 10 min, which appeared in the form of
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FIG. 1. Contraction-mediated GLUT4-EGFP translocation to both sarcolemma and t-tubules. A and B: Examples of the regions of interest (ROIs)
used for image quantiﬁcations. A: Fluorescence values of GLUT4-EGFP perinuclear and nonperinuclear depots were measured within the same
ROI. Quantiﬁcation software settings were set to measure vesicles >2 m in size inside the ROI and to discriminate between perinuclear and
nonperinuclear depots. B: The level of GLUT4-EGFP translocation in the muscle ﬁbers at the different time points was measured in ROIs along
each sarcolemma side and in four randomly chosen ROIs in the t-tubules region. Translocation ROIs excluded vesicles structures above 2 mi n
size. C: In vivo staining of t-tubules after intravenous injection of the water soluble dye sulforhodamine B, showing a high ﬂuorescence staining
in the capillaries running along the sarcolemma together with a more weakly ﬂuorescent striated pattern in the t-tubules region. D and E: t 
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There was also the emergence of t-tubule region striations
(Fig. 1E [t  10] and G). The increases in GLUT4-EGFP at
the sarcolemma and t-tubules were accompanied by a 30%
decrease in intracellular GLUT4 vesicle depots (Fig. 1E
and H). During two additional 10-min periods of contrac-
tions, translocation to the sarcolemma and t-tubules
steadily increased, and GLUT4-EGFP vesicle depots were
further reduced (Fig. 1E [t  20, t  30, diagonal arrow]
and F–H). Peak GLUT4-EGFP staining of the sarco-
lemma (Fig. 1E)( t  30, horizontal arrow) and t-tubules
(Fig. 1E)( t  30, striated pattern) occurred at the same
time, indicating that GLUT4 translocation to these dis-
tinct cell surface membranes followed similar kinetics
(Fig. 1F–H). This is in contrast to what we have
previously reported for insulin-mediated GLUT4-EGFP
translocation (5). Comparison of high- and low-voltage
contraction revealed that the high-voltage protocol re-
sulted in greater levels of GLUT4-EGFP translocation to
the sarcolemma and t-tubules and a greater decrease in
GLUT4 vesicle depots (Fig. 1F–H).
Kinetics of GLUT4-EGFP re-internalization. We next
investigated the kinetics of GLUT4-EGFP re-internaliza-
tion in the period following muscle contractions, using the
3  5 min high-voltage contraction protocol that resulted
in maximal translocation. Similar to the previous experi-
ment (Fig. 1), GLUT4-EGFP translocation to the sarco-
lemma and t-tubules increased gradually throughout the
contractions, and there was a concomitant decrease in
intracellular depots (Fig. 2). Interestingly, peak GLUT4-
EGFP depot depletion had occurred by 10 min (Fig. 2A
[t  10] and D), whereas GLUT4-EGFP translocation to the
sarcolemma and t-tubules continued to increase during the
ﬁrst 10 min following the cessation of contractions (Fig.
2A [t 
 10] and B,C). This indicates a delay in the arrival
of GLUT4-EGFP at the sarcolemma and t-tubules. Follow-
ing peak translocation to the sarcolemma and t-tubules,
GLUT4-EGFP underwent gradual net re-internalization
and was almost fully re-internalized by 130 min after
contractions (Fig. 2A–C). In parallel, GLUT4-EGFP re-
emerged in the depots (Fig. 2A and D). The time course of
GLUT4-EGFP re-internalization was similar for the sarco-
lemma and t-tubules (Fig. 2A–C).
Contraction-stimulated GLUT4-EGFP translocation
and re-internalization are normal in AMPK2 inac-
tive transgenic mice. AMPK has been proposed to regu-
late contraction-stimulated glucose transport in skeletal
muscle, although there is now considerable data suggest-
ing that AMPK is not necessary for this process (24,27,28).
The role of AMPK in regulating GLUT4 translocation
kinetics in skeletal muscle has not been studied. Here,
contraction-regulated GLUT4-EGFP kinetics were com-
pared in AMPK2 inactive transgenic mice and their
wild-type littermates. In the basal state, there was a
normal distribution of GLUT4-EGFP in the intracellular
depots and the perinuclear area (Fig. 3A and B)( t  0,
diagonal and vertical arrow), with no continuous presence
at the sarcolemma and no regular continuous striated
pattern (Fig. 3A and B [t  0]). Thus, ablation of AMPK2
activity did not affect GLUT4-EGFP localization in the
basal state.
AMPK2 inactive mice and their matched controls were
subjected to 2  5 min of high-voltage stimulation. After
contractions, GLUT4-EGFP was redistributed from the
basal depots (Fig. 3A)( t  0, t  10, diagonal and vertical
arrows) to the sarcolemma (Fig. 3A)( t  10, horizontal
arrow) and t-tubules (Fig. 3A)( t  10, striated pattern).
During 60 min of recovery, basal GLUT4-EGFP distribu-
tion was reestablished (Fig. 3A)( t  60). When compared
with controls, there was no difference in GLUT4-EGFP
translocation and re-internalization (Fig. 3B). Image quan-
tiﬁcation showed that maximal translocation was reached
at t  10 min for both the sarcolemma (260% above
basal) (Fig. 3C) and t-tubules (275% above basal) (Fig.
3D). This was accompanied by a 65% reduction in GLUT4-
EGFP, corresponding to 65% maximal reduction in nonpe-
rinuclear depots and a 55% maximal reduction in
perinuclear GLUT4-EGFP depots (Fig. 3E). Re-internaliza-
tion of GLUT4-EGFP occurred immediately after contrac-
tions with similar rates for the sarcolemma and t-tubules
indicating similar kinetics (Fig. 3C and D). Ablation of
AMPK2 activity did not inﬂuence GLUT4-EGFP kinetics
in response to contractions (Fig. 3C–E). Thus, AMPK2
activity is not necessary for normal GLUT4 trafﬁcking
kinetics before, during, and after in situ contractions in
living animals.
AICAR-stimulated GLUT4-EGFP translocation and
re-internalization. A previous study suggested that the
AMPK activator AICAR only increases GLUT4 transloca-
tion to the sarcolemma and not to the t-tubules (23).
However, this ﬁnding is not consistent with the central
role of the t-tubules in GLUT4 translocation (4,5,35) and
glucose transport (15,35) and the ﬁnding that AICAR
stimulates glucose transport to the same extent as insulin
and contraction (20). Therefore, we investigated the ef-
fects of AICAR on GLUT4-EGFP translocation kinetics.
AICAR was injected as a bolus into the tail vein immedi-
ately after t  0, and the ﬁrst post-injection image was
obtained 10 min later. AICAR resulted in a gradual but
signiﬁcant increase in staining along the sarcolemma by
20–40 min after AICAR injection (Fig. 4A [t  20–40] and
B [supplementary video 2]). Furthermore, a clear striated
pattern appeared by 20–40 min after AICAR injection
demonstrating GLUT4-EGFP translocation to the t-tubules
(Fig. 4A [t  20–40] and C [supplementary video 2]).
Maximal translocation occurred 90–100 min after AICAR
injection with a 300% increase above basal for both the
sarcolemma and t-tubules. Increased GLUT4-EGFP at the
sarcolemma and t-tubules was accompanied by a gradual
redistribution of GLUT4-EGFP from depots (Fig. 4). The
depot depletion corresponded to a 70% maximal reduction
in nonperinuclear depots and a 60% maximal reduction in
perinuclear GLUT4-EGFP depots. GLUT4-EGFP vesicles
were depleted 20 min after AICAR injection (Fig. 4) (t 
20, supplementary video 2), and depletion further pro-
gressed at 80 min (Fig. 4D). Re-internalization of GLUT4-
0 shows confocal images of basal GLUT4-EGFP–expressing ICR mouse muscle ﬁbers just before in situ contractions. Repeated single contractions
(2 Hz) were elicited using either “high” (1.1–3 V) (D) or “low” (0.1–0.9 V) (E) voltage. Muscle was stimulated for 3  5 min (D)o r3 10 min
(E) periods separated by 90 sec of rest. Images are shown from one muscle ﬁber subjected to either high- (D) or low-voltage (E) contractions.
Horizontal arrows indicate sarcolemma, while GLUT4-EGFP depots are indicated near the nuclei by vertical arrows and inside the ﬁber by
diagonal arrows. Similar observations were done in ﬁbers from ﬁve to eight mice. Numbers denote time in min. Bars  20 m. F-H: Image
quantiﬁcations of GLUT4-EGFP at the sarcolemma (F), the t-tubules (G), and the intracellular vesicle depots (H). *Statistical difference between
groups (P < 0.05) in values obtained at the end of identical contraction bouts. Arbitrary units shown are the actual grey value of ROI ﬂuorescence
divided by ROI ﬂuorescence value at t  0 (f/f0). Data are means  SE. n  5–8.
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identical time course (Fig. 4). Maximal translocation did
not differ in response to AICAR (Fig. 4) and contractions
(Figs. 1 and 2), and re-internalization kinetics were also
similar in comparing the two stimuli (Figs. 1, 2, and 4).
Thus, AICAR stimulates GLUT4-EGFP translocation to
both the sarcolemma and t-tubules in a similar manner to
muscle contraction.
AICAR-stimulated GLUT4-EGFP translocation is im-
paired in AMPK2 inactive transgenic mice. We deter-
mined if AMPK2 was necessary for AICAR-stimulated
GLUT4-EGFP translocation. Compared with control mice,
the AMPK2 inactive transgenic mice had minor staining
along the sarcolemma (Fig. 5A and C) and very weak
striations in the t-tubule region following AICAR injection
(Fig. 5B and D). Furthermore, there was only limited
depletion of GLUT4-EGFP vesicle depots (Fig. 5B and E).
It is interesting that the changes in the GLUT4-EGFP
depots did not fully match sarcolemma and t-tubule
GLUT4-EGFP, as there was a modest depletion of GLUT4-
EGFP depots without an accompanying increase at the
cell surface membranes (Fig. 5C–E). Based on our expe-
rience with this method, we believe that there is also an
intermediate step in the GLUT4 translocation and re-
internalization processes that appear as a light back-
ground “haze” upon imaging, and this haze can be
observed in Fig. 5A.
The minimal GLUT4-EGFP translocation that is present
in these mice may be due to very low levels of AMPK1
subunit in the muscle ﬁbers and/or from nonspeciﬁc
systemic effects of AICAR. In fact, we observed that
injection of AICAR caused minor trembling of the mice
(this can be seen as the muscle ﬁber vibrating in ﬁrst half
of supplementary video 2). Thus, the majority of the
AICAR-induced GLUT4-EGFP translocation is abolished in
AMPK2 inactive transgenic mice.
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FIG. 2. In situ contractions induce GLUT4-EGFP translocation to and re-internalization from both sarcolemma and t-tubules with similar kinetics.
A: t0 shows confocal image of a basal GLUT4-EGFP–expressing muscle ﬁber just before in situ contractions in an ICR mouse. Contractions were
elicited using the high-voltage protocol for 3  5 min separated by 90 sec of rest. Horizontal arrows indicate sarcolemma, while GLUT4-EGFP
depots are indicated near the nuclei by vertical arrows and inside the ﬁber by diagonal arrows. Similar observations were done in ﬁbers from ﬁve
to eight mice. t  denotes accumulated contraction time; t denotes time during recovery after contractions. Bar  20 m. B-D: Image
quantiﬁcations of GLUT4-EGFP at the sarcolemma (B), the t-tubules (C), and the intracellular vesicle depots (D). Horizontal solid lines indicate
contraction period. Horizontal dotted lines indicate the period after contractions. Data are means  SE. n  5–8.
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FIG. 3. AMPK activity does not affect GLUT4-EGFP basal localization and translocation and re-internalization kinetics in response to in situ
contractions. A and B: t  0 shows confocal images of basal GLUT4-EGFP–expressing muscle ﬁbers immediately before in situ contractions in
either a muscle-speciﬁc AMPK2 inactive transgenic mouse (A) or a matched control mouse (B). Contractions were elicited using the
high-voltage protocol for 2  5 min separated by 90 sec of rest. Horizontal arrows indicate sarcolemma, while GLUT4-EGFP depots are indicated
near the nuclei by vertical arrows and inside the ﬁbers by diagonal arrows. Similar observations were made in ﬁbers from ﬁve mice in each group.
Numbers denote time in min during (t ) and after (t  ) contractions. Bars  20 m. C–E: Image quantiﬁcations of GLUT4-EGFP at the
sarcolemma (C), the t-tubules (D), and the intracellular vesicle depots (E). Horizontal solid lines indicate contraction period. Horizontal dotted
lines indicate the period after contractions. Data are means  SE. n  5.
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Physical exercise is accepted as an important modality to
decrease blood glucose concentrations in patients with
diabetes. Despite the importance of exercise in the main-
tenance of overall glucose homeostasis, the cellular ma-
chinery that controls contraction-stimulated glucose
transport is poorly understood. In the current study, we
used a newly developed imaging technique to investigate
GLUT4 translocation by directly monitoring the kinetics
of intramuscular GLUT4-EGFP translocation before,
during, and after contraction of skeletal muscle ﬁbers in
living mice. We found that contraction increases GLUT4
translocation to both sarcolemma and t-tubules, this
effect is voltage dependent, and GLUT4 on the cell
surface membranes is increased for more than 2 h after
the cessation of contraction. In examining a putative
signaling mechanism, we found that AMPK2 activity is
not necessary for contraction-stimulated GLUT4 trans-
location.
Translocation to the sarcolemma and t-tubules, as well
as depletion of intracellular vesicle depots, was higher in
response to contractions elicited by higher voltage despite
a 50% shorter duration of contraction compared with the
low-voltage protocol. In addition, the high-voltage pro-
tocol resulted in a continuous increase in GLUT4-EGFP
translocation to the sarcolemma and t-tubules for the
15-min period even though maximal intracellular
GLUT4-EGFP vesicle depletion had occurred by 10 min
(Fig. 1). The mechanism for the delay is not known;
however, it could be the result of the ability of high-
voltage contraction to accelerate depletion of GLUT4-
EGFP storage vesicles rapidly, combined with a
potential “bottleneck” at the exocytic/fusion step at the
cell surface membranes. Such a bottleneck at the fusion
step of GLUT4-EGFP translocation has previously been
shown to occur in primary adipocytes (10). The magni-
tude of the increase in GLUT4-EGFP translocation was
similar to that observed with myc-tagged-GLUT4 in
time (min)
0 50 100 150 200 250 300
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
f
/
f
0
Sarcolemma
time (min)
0 50 100 150 200 250 300
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
T-tubules
time (min)
0 50 100 150 200 250 300
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1.1 Depots
t=0 t=20 t=10 t=40
t=80 t=160 t=120 t=240
A
BC D
FIG. 4. AICAR stimulation induces GLUT4-EGFP translocation to both sarcolemma and t-tubules with similar kinetics. A: t  0 shows a confocal
image of a basal GLUT4-EGFP–expressing muscle ﬁber in situ immediately prior to intravenous AICAR administration via the tail vein of an
anesthetized ICR mouse. Horizontal arrows indicate sarcolemma, while GLUT4-EGFP depots are indicated near the nuclei by vertical arrows and
inside the ﬁber by diagonal arrows. Similar observations were made in ﬁbers from ﬁve mice. Numbers denote time in min. Bar  20 m. B–D:
Image quantiﬁcations of GLUT4-EGFP at the sarcolemma (B), the t-tubules (C), and the intracellular vesicle depots (D). Data are means 
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tracted mouse muscle (37) and collagenase-derived
cardiomyocytes (38), although neither of these studies
were performed in live animals.
Current theory suggests that excitation-contraction cou-
pling in the individual muscle ﬁber occurs as an all or
nothing event (17), and therefore an increase in stimula-
tion above a threshold level would not have an additional
effect on that muscle ﬁber. In contrast, our observations,
which followed GLUT4 translocation throughout the en-
tire contraction treatment in the same muscle ﬁbers,
indicate that voltage-dependent regulatory mechanisms
exist within individual ﬁbers. Thus, metabolically derived
signals may control the magnitude and duration of con-
traction-stimulated GLUT4 translocation as opposed to
mechanically derived stimulation.
It is well established that there are distinct signaling
mechanisms for exercise- and insulin-stimulated glucose
transport, due in part to data demonstrating that the
combination of a maximal insulin stimulus plus a maximal
contraction stimulus has additive effects on glucose trans-
port (19,39) and GLUT4 translocation (4). Some studies
suggest there are different intracellular pools of GLUT4,
one stimulated by insulin and one stimulated by exercise
(18,40,41). Although the current data do not directly
support the possibility of different pools of GLUT4 in
muscle, they do demonstrate that the spatial temporal
kinetics of contraction- and insulin-stimulated GLUT4
translocation differ substantially. In a previous investiga-
tion, we analyzed recruitment, translocation, steady-state
recycling, and subsequent re-internalization of GLUT4 in
response to insulin in live mice. With insulin stimulation,
we found GLUT4-EGFP translocation to the sarcolemma
to be faster than GLUT4-EGFP translocation in the t-
tubules. The delay was found to originate from a difference
in initiation of the insulin signal. In parallel, GLUT4-EGFP
re-internalization was also completed earlier at the sarco-
lemma compared with the t-tubules. In contrast, in the
present study, we found that the kinetics of contraction-
stimulated GLUT4 translocation and re-internalization to
and from the sarcolemma and t-tubules are similar for the
two compartments. These differences in GLUT4 transloca-
tion kinetics provide further evidence that the insulin- and
contraction-stimulated translocation mechanisms for
GLUT4 are distinct. One of the reasons for this difference
could be that the contraction impulses spread rapidly at a
similar rate throughout the cell to both the t-tubules and
sarcolemma during excitation-contraction coupling. In
contrast, insulin stimulation is initiated as insulin arrives
ﬁrst at the sarcolemma and, in turn, slowly diffuses into
the t-tubules (5). Another possible reason could be that the
signaling/translocation cascade differs between the sarco-
lemma and t-tubules for insulin stimulation, whereas the
contraction cascade does not.
In addition to contraction and insulin, there are many
other stimuli that increase glucose transport in skeletal
muscle (20). The AMPK activator AICAR increases glucose
transport and, through the use of subcellular fractionation,
we (36) and another group (23) have shown that AICAR
increases GLUT4 translocation. A more recent report (42)
utilized a photolabeling technique and showed that AICAR
increased GLUT4 translocation to the membrane fraction
of rat muscle strips to the same extent as a supraphysi-
ological insulin dose. Surprisingly, in another report (23),
AICAR was shown to only stimulate GLUT4 translocation
to the sarcolemmal membranes and not to the t-tubules.
In the current investigation, AICAR clearly resulted in
GLUT4 translocation to both the sarcolemma and t-tu-
bules, and this redistribution of GLUT4 to the two mem-
brane compartments adhered to similar kinetics. The
discrepancy may be due to very different experimental
techniques with subcellular fractionation methods that are
less sensitive. Given our current ﬁndings, the fact that
AICAR has robust effects on glucose transport and that
detubulation experiments indicate a predominant role
of t-tubules in regulating glucose transport in muscle
(15,35), we believe t-tubules play a signiﬁcant role in the
regulation of AICAR-stimulated glucose transport.
AMPK activation has been proposed to be the key
regulator of contraction-stimulated GLUT4 translocation
(43), and AMPK activation by AICAR has been shown to
increase glucose transport in skeletal muscle to the same
extent as contractions (27). Consistent with these ﬁndings,
we observed that AICAR and contractions resulted in
similar increases in GLUT4 translocation in muscle ﬁbers.
To determine the role of AMPK2 in AICAR- and
contraction-stimulated GLUT4 localization and trafﬁck-
ing, we studied AMPK2 inactive transgenic mice.
AICAR-stimulated GLUT4-EGFP translocation was
markedly reduced in the AMPK2 inactive mice, consis-
tent with previous results measuring abolished glucose
transport (25,27). Interestingly, contraction-stimulated
GLUT4 translocation and re-internalization kinetics for
both the sarcolemma and t-tubules were identical in
mice with ablated AMPK2 activity. This is in line with
a report that used subcellular fractionation to show that
exercise in AMPK2 kinase dead transgenic mice results
in normal GLUT4 translocation (28). Our GLUT4 trans-
location ﬁndings are consistent with studies showing
only partial (25) or no (27) inhibition of glucose trans-
port in models of ablated AMPK2. Thus, either AMPK
is not involved in contraction-induced GLUT4 translo-
cation or redundant mechanisms mediate signaling to
the intracellular GLUT4 vesicle depots. Interestingly,
ablation of AMPK2 activity had no effect on basal
distribution of GLUT4.
In summary, this study determined the effects of
contraction on GLUT4 translocation and re-internaliza-
tion kinetics directly in the skeletal muscle of living
mice. To describe GLUT4 translocation with muscle
contraction, we and other groups have previously used
a laborious subcellular fractionation methodology
(44,45). This early work demonstrated that both insulin
and exercise increase glucose uptake via GLUT4 trans-
location from an intracellular pool to the plasma mem-
brane. However, the novel microscopy technique
described here has allowed us to signiﬁcantly advance
this line of investigation. By monitoring the localization
and movement of ﬂuorescent-labeled GLUT4 by confo-
cal microscopy in the muscle ﬁbers of anesthetized
mice, we can observe the spatial-temporal details of
GLUT4 localization and translocation. Previously, this
level of quality and resolution of imaging was only
possible in cell culture systems. In future studies, this
method can be used to address important questions
concerning contraction-induced GLUT4 translocation,
such as how the GLUT4 vesicles interact with other
proteins of the translocation machinery and the signals
regulating GLUT4 translocation.
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